p 825.90 <%= Resources.Global.txtDown %>
Updated 12/12/2018
Change % -0.07% Stock price decreasing
Change -0.601 Stock price decreasing
Volume 195,920
High P 841.50
Low P 824.50
Open P 825.00
ISIN GB0001001592
Prev close P 826.50
# of shares 387.19M
Market cap 319,780M GBX
Intraday

Market closed
BTG PLC ORD 10P
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  825.90 -0.2% Stock price decreasing 25.4% Stock price increasing 47.9% Stock price increasing 52.4% Stock price increasing 8.9% Stock price increasing
Powered by TradingView

Company profile

BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. The revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
14 December 2018 17:54:53
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB3 - 2018-12-14 18:54:53 - 2018-12-14 17:54:53 - 1000 - Website: OKAY